Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Oncogenic pathway signatures predict the risk of progression and recurrence in well‐differentiated pancreatic neuroendocrine tumors

Journal of Surgical Oncology(2024)10.1002/jso.27830Source: DataRank Database

Oncogenic pathway signatures predict the risk of progression and recurrence in well‐differentiated pancreatic neuroendocrine tumors is a research paper published in Journal of Surgical Oncology (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: hybridTopics (21)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Colin M. Court ORCID,Benjamin J. DiPardo,Joseph R. Pisegna ORCID,David W. Dawson ORCID,O. Joe Hines ORCID

Live enrichment

PubMed:39155697 PMC:PMC11654900

NCI NIH HHS

Grant: R01 CA222877

NCI/NIH

Grant: R01CA227089

NCI NIH HHS

Grant: P50 CA092131

NCI NIH HHS

Grant: P30 CA016042

NCI NIH HHS

Grant: P50 CA211015

NCI NIH HHS

Grant: P01 CA168585

Hirshberg Foundation for Pancreatic Research

W.M. Keck Foundation

hybridLicense: cc-by-nc-nd

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jso.27830

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.27830

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jso.27830

repositoryhttps://escholarship.org/content/qt481649jp/qt481649jp.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11654900/pdf/JSO-130-1070.pdf

MeSH Terms

HumansNeuroendocrine TumorsPancreatic NeoplasmsNeoplasm Recurrence, LocalDisease ProgressionPrognosisSurvival RateFollow-Up StudiesMutationAdultAgedMiddle AgedFemaleMaleBiomarkers, TumorExome Sequencing

Keywords

PrognosisRecurrencePancreatic Neuroendocrine TumorGenomic BiomarkerWhole‐exome Sequencing